Literature DB >> 3242694

Tandem mass spectrometric studies of the fragmentation of penicillins and their metabolites.

S Suwanrumpha1, D A Flory, R B Freas, M L Vestal.   

Abstract

The fragmentation of two penicillins, ampicillin and amoxicillin, and their principal metabolites has been studied by a combination of liquid chromatography/thermospray mass spectrometry and tandem mass spectrometry. A high-resolution tandem mass spectrometer was used to obtain chemical ionization, fast-atom bombardment, and collision-induced dissociation mass spectra. Structural information and fragmentation mechanisms have been deduced from ions in the mass and collision spectra. This knowledge is useful in the analysis and identification of metabolites of ampicillin and related drugs in human body fluids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3242694     DOI: 10.1002/bms.1200160175

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  3 in total

1.  Metabolic Profiling and In Vitro Assessment of the Biological Activities of the Ethyl Acetate Extract of Penicillium chrysogenum "Endozoic of Cliona sp. Marine Sponge" from the Red Sea (Egypt).

Authors:  Muneera S M Al-Saleem; Wafaa H B Hassan; Zeinab I El Sayed; Mahmoud M Abdel-Aal; Wael M Abdel-Mageed; Eman Abdelsalam; Sahar Abdelaziz
Journal:  Mar Drugs       Date:  2022-05-15       Impact factor: 6.085

2.  A Comprehensive Study to Identify Major Metabolites of an Amoxicillin-Sulbactam Hybrid Molecule in Rats and Its Metabolic Pathway Using UPLC-Q-TOF-MS/MS.

Authors:  Fei-Ke Zhao; Ren-Bin Shi; Yu-Bin Sun; Shuang-Yun Yang; Liang-Zhu Chen; Bing-Hu Fang
Journal:  Metabolites       Date:  2022-07-18

3.  Identification of the related substances in ampicillin capsule by rapid resolution liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

Authors:  Lei Zhang; Xian Long Cheng; Yang Liu; Miao Liang; Honghuan Dong; Beiran Lv; Wenning Yang; Zhiqiang Luo; Mingmin Tang
Journal:  J Anal Methods Chem       Date:  2014-11-04       Impact factor: 2.193

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.